Pharming Group NV (PHAR): שווי כולל של נכסי החברה

Pharming Group N.V. (PHAR) is implementing eco-friendly synthesis methods for biological products, strictly adhering to research ethics and waste disposal standards. The business relies on patent protection for orphan drugs and a unique protein extraction technology. This price chart shows that the shares reflect total assets at 456.50. The brand's high authority within the scientific community and the trust of patients with immune pathologies confirm the ethical orientation of the company's strategy.

Pharming Group N.V. (PHAR) maintains a monopoly position in the orphan drug segment, guaranteeing high margins and a steady cash flow. By analyzing total assets via ROA, an investor can determine the company's total resource value, calculated inversely through return on assets for real-time capital monitoring. This price action allows for a real-time assessment of asset base management efficiency, thereby defining the fundamental value of the business.